{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:13:33Z","timestamp":1773213213425,"version":"3.50.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":447,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"LabCorp"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1111\/bjd.12801","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T23:08:29Z","timestamp":1387580909000},"page":"403-408","source":"Crossref","is-referenced-by-count":12,"title":["Neuropilin-2 gene expression correlates with malignant progression in cutaneous melanoma"],"prefix":"10.1093","volume":"171","author":[{"given":"M.","family":"Rossi","sequence":"first","affiliation":[{"name":"Department of Dermatology; Boston University School of Medicine; 609 Albany Street Boston MA 02118 U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Tuck","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Boston University School of Medicine; 609 Albany Street Boston MA 02118 U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.-J.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Boston University School of Medicine; 609 Albany Street Boston MA 02118 U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Panova","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Boston University School of Medicine; 609 Albany Street Boston MA 02118 U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.T.","family":"Symanowski","sequence":"additional","affiliation":[{"name":"Department of Biostatistics; Levin Cancer Institute; Charlotte NC U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mahalingam","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Boston University School of Medicine; 609 Albany Street Boston MA 02118 U.S.A"},{"name":"Dermatopathology Section; Boston University School of Medicine; 609 Albany Street Boston MA 02118 U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.I.","family":"Riker","sequence":"additional","affiliation":[{"name":"Advocate Christ Medical Center and Cancer Institute; Oak Lawn IL U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Alani","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Boston University School of Medicine; 609 Albany Street Boston MA 02118 U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ryu","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Boston University School of Medicine; 609 Albany Street Boston MA 02118 U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"key":"10.1111\/bjd.12801-BIB0001|bjd12801-cit-0001","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12801-BIB0002|bjd12801-cit-0002","first-page":"488","article-title":"Treatment of metastatic melanoma: an overview","volume":"23","author":"Bhatia","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"10.1111\/bjd.12801-BIB0003|bjd12801-cit-0003","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1468-3083.2007.02475.x","article-title":"Systemic therapy of disseminated malignant melanoma: an evidence-based overview of the state-of-the-art in daily routine","volume":"21","author":"Nashan","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12801-BIB0004|bjd12801-cit-0004","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.bcp.2010.04.017","article-title":"Using genetics and genomics strategies to personalize therapy for cancer: focus on melanoma","volume":"80","author":"Nathanson","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/bjd.12801-BIB0005|bjd12801-cit-0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-4615-0119-0_3","article-title":"The role of neuropilin in vascular and tumor biology","volume":"515","author":"Klagsbrun","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/bjd.12801-BIB0006|bjd12801-cit-0006","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0092-8674(00)80535-8","article-title":"Neuropilin is a semaphorin III receptor","volume":"90","author":"Kolodkin","year":"1997","journal-title":"Cell"},{"key":"10.1111\/bjd.12801-BIB0007|bjd12801-cit-0007","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.yexcr.2005.11.024","article-title":"Neuropilins in neoplasms: expression, regulation, and function","volume":"312","author":"Bielenberg","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1111\/bjd.12801-BIB0008|bjd12801-cit-0008","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1158\/0008-5472.CAN-10-1875","article-title":"Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction","volume":"71","author":"Stine","year":"2011","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12801-BIB0009|bjd12801-cit-0009","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.humpath.2011.05.008","article-title":"Neuropilin-2: a novel biomarker for malignant melanoma?","volume":"43","author":"Rushing","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1111\/bjd.12801-BIB0010|bjd12801-cit-0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9440(10)63093-3","article-title":"Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay","volume":"164","author":"Cronin","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12801-BIB0011|bjd12801-cit-0011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-8794-1-13","article-title":"The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis","volume":"1","author":"Riker","year":"2008","journal-title":"BMC Med Genomics"},{"key":"10.1111\/bjd.12801-BIB0012|bjd12801-cit-0012","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/sj.bjc.6604316","article-title":"Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours","volume":"98","author":"Linton","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12801-BIB0013|bjd12801-cit-0013","doi-asserted-by":"crossref","first-page":"e29143","DOI":"10.1371\/journal.pone.0029143","article-title":"A reliable method for the selection of exploitable melanoma archival paraffin embedded tissues for transcript biomarker profiling","volume":"7","author":"Lebbe","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1111\/bjd.12801-BIB0014|bjd12801-cit-0014","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0560.2010.01505.x","article-title":"Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study","volume":"37","author":"Nazarian","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1111\/bjd.12801-BIB0015|bjd12801-cit-0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.5858\/arpa.2011-0360-OA","article-title":"Automated quantification of MART1-verified Ki67 indices by digital image analysis in melanocytic lesions","volume":"136","author":"Nielsen","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/bjd.12801-BIB0016|bjd12801-cit-0016","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMra041245","article-title":"Management of cutaneous melanoma","volume":"351","author":"Tsao","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.12801-BIB0017|bjd12801-cit-0017","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/jid.2010.149","article-title":"Biomarkers: the useful and the not so useful - an assessment of molecular prognostic markers for cutaneous melanoma","volume":"130","author":"Gould Rothberg","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12801-BIB0018|bjd12801-cit-0018","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/jso.21969","article-title":"Prognostic molecular biomarkers for cutaneous malignant melanoma","volume":"104","author":"Tanaka","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1111\/bjd.12801-BIB0019|bjd12801-cit-0019","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/CCO.0b013e328337fe8f","article-title":"The biology behind prognostic factors of cutaneous melanoma","volume":"22","author":"Spatz","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1111\/bjd.12801-BIB0020|bjd12801-cit-0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1053\/j.seminoncol.2007.09.009","article-title":"Angiogenesis in melanoma","volume":"34","author":"Mahabeleshwar","year":"2007","journal-title":"Semin Oncol"},{"key":"10.1111\/bjd.12801-BIB0021|bjd12801-cit-0021","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0002-9440(10)64922-X","article-title":"Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor\/fibroblast growth factor receptor-1 and ephrin-A1\/EphA2 on melanoma progression","volume":"160","author":"Straume","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12801-BIB0022|bjd12801-cit-0022","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaad.2012.07.009","article-title":"Neuropilin-2 as a useful marker in the differentiation between Spitzoid malignant melanoma and Spitz nevus","volume":"68","author":"Wititsuwannakul","year":"2013","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12801","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12801\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:08:15Z","timestamp":1676383695000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/171\/2\/403\/6615620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12801","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6,11]]}}}